Evidence Shows Higher Risk of C. difficle Infection with PPIs

Learn More From Dr. Yoon K. Loke on the AJG Podcast

Findings from a new meta-analysis portray a cautionary tale on the use of PPI therapy in patients at significant risk of C. difficile infection. In conversation with AJG Co-Editor, Dr. William D. Chey, MD, Dr. Yoon K. Loke discusses his research findings that suggest concurrent use of antibiotics with PPIs increases the risk of CDI; and a lower risk of CDI with use of H2RAs. (17:00)

Read the Article

Download from iTunes

Listen to the Podcast